BioCentury
ARTICLE | Company News

Vernalis gets frovatriptan approved

July 21, 2000 7:00 AM UTC

Vernalis (LSE:VER), formerly Vanguard Medica, received French approval for Migard frovatriptan to treat migraine. The product will undergo review for the rest of the EU states under the mutual recogni...